Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Law Firms
Life Sciences
High-Tech
Competitor Tech Research
Design Risk Screening
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How arginase inhibitors, arginine-depleting enzymes, and metabolic checkpoint combinations are reshaping immunotherapy for solid tumors. Evidence-based pipeline analysis.
Article | Report A 2026 technology landscape of electrochemical formic acid production via CO₂ electroreduction: catalysts, reactors, current densities, and commercial readiness signals.
Article | Report How to reduce parasitic reactions at the anode-electrolyte interface in potassium-ion batteries for low-cost stationary storage — SEI engineering, electrolyte design, and anode strategies.
Article | Report PLK4 and centrosome amplification inhibitors in solid tumors: CFI-400945, YLT-11, centrinone, and combination strategies across TNBC, prostate, and pediatric cancers.
Article | Report A 2026 technology landscape of plasma activated water (PAW): generation methods, antimicrobial efficacy, agricultural uses, key patents, and emerging IP opportunities.
Article | Report How ML potentials and AI-driven MD simulation cut computational cost of solid electrolyte interface prediction by orders of magnitude. Analysis of 20+ patents and papers.
Article | Report MCL-1 overexpression drives venetoclax resistance in AML, DLBCL, and myeloma. Explore direct inhibitors, CDK9 suppression, NOXA induction, and combination strategies.
Article | Report Mapping the 2026 quantum dot solar concentrator patent and literature landscape: LSC efficiencies, QDSSC records, geographic IP hotspots, and emerging eco-design strategies.
Article | Report How to improve oxidation stability of sulfide solid electrolytes at the cathode interface without sacrificing ionic conductivity — strategies from 20+ patents and studies.
Article | Report Explore the 2026 electrochemical methane activation landscape: key catalyst clusters, SOEC selectivity data, ambient-condition breakthroughs, and strategic IP implications.
Article | Report How aryl-sulfonamide molecular glues degrade RBM39 via CRL4-DCAF15, driving activity in leukemia, neuroblastoma, and ovarian cancer. Pipeline and IP signals.
Article | Report How single-ion conducting polymer electrolytes push lithium transference numbers toward unity, eliminate concentration polarization, and suppress dendrite growth in lithium metal batteries.
Article | Report A deep-dive into thermoelectric module packaging innovation: hermetic encapsulation, flexible substrates, IC spot-cooling, and the assignees shaping the 2026 landscape.
Article | Report How cryo-EM reveals atomic-scale SEI nanostructure in lithium-metal, lithium-ion, and sodium batteries — key findings, workflows, and research trends.
Article | Report How NPC and NSC therapies are advancing stroke recovery, spinal cord injury, and neurodegeneration — from iPSC-derived cells to Phase II trials.